The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) valued at $109,085,460 to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of approximately 3.9 million Albuterol HFA inhalers with dose counters annually over a five-year period, with an initial one-year base period and four one-year option periods.
The contracted products will be distributed through the VA's Pharmaceutical Prime Vendor Program to support the pharmaceutical needs of the VA, Bureau of Prisons, and Indian Health Service. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various U.S. federal government agencies, providing a wide range of pharmaceutical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs. This IDC award demonstrates Teva's significant role in ensuring a stable supply of essential medications to federal healthcare programs.
Generated 1/9/25, 9:03 AM